Cover Image

Potential reversal of pulmonary vasoplegia by inhaled ibuprofenate in COVID‐19 pneumonia

Saved in:

Bibliographic Details
Main Authors:	Christian Carlos Zurita‐Lizza (Author), Pablo Alexis Doreski (Author)
Format:	Book
Published:	Wiley, 2022-03-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Blocking the action of NLRP3 inflammasome by inhaled ibuprofenate on pulmonary macrophages infected by SARS‐CoV‐2
by: Christian Carlos Zurita‐Lizza, et al.
Published: (2023)

Repurposing Inhaled Ibuprofenate, a Non Steroidal Anti‐Inflammatory Drug, as a Potential Adjuvant Treatment for Pneumonia, CARDS and its Aetiological Agent SARS‐CoV‐2
by: Christian Carlos Zurita‐Lizza, et al.
Published: (2023)

Nitrooxyethylation Reverses the Healing-Suppressant Effect of Ibuprofen
by: Mandeep Kaushal, et al.
Published: (2006)

Pulmonary embolism in an adolescent with COVID-19 pneumonia
by: Héctor Nuñez-Paucar, et al.
Published: (2023)

Safe use of ibuprofen in COVID-19 in children
by: T.P. Borysova
Published: (2022)

COVID-19 - Therapeutic controversies. The case of ibuprofen
by: Camil-Eugen Vari, et al.
Published: (2020)

Impact of Leucine and Magnesium Stearate on the Physicochemical Properties and Aerosolization Behavior of Wet Milled Inhalable Ibuprofen Microparticles for Developing Dry Powder Inhaler Formulation
by: Shahjabeen Sharif, et al.
Published: (2023)

Preparation of Ibuprofen-Loaded Inhalable γCD-MOFs by Freeze-Drying Using the QbD Approach
by: Anett Motzwickler-Németh, et al.
Published: (2024)

Protective effect of inhaled corticosteroid on children with asthma with Mycoplasma pneumoniae pneumonia
by: Bing Wei, et al.
Published: (2022)

COVID-19: Should you be concerned about the use of ibuprofen?
by: Ewa Obońska, et al.
Published: (2021)

Preparation and Characterization of Ibuprofen Containing Nano-Embedded-Microparticles for Pulmonary Delivery
by: Petra Party, et al.
Published: (2023)

Inhaled Corticosteroids and the Pneumonia Risk in Patients With Chronic Obstructive Pulmonary Disease: A Meta-analysis of Randomized Controlled Trials
by: Hong Chen, et al.
Published: (2021)

Pulmonary embolism in a young man infected with COVID-19 pneumonia
by: Arda Can Doğan, et al.
Published: (2020)

Pulmonary hematoidin deposition in a case of severe COVID19 pneumonia
by: Nada Shaker, et al.
Published: (2022)

Comprehensive In Vitro and In Silico Aerodynamic Analysis of High-Dose Ibuprofen- and Mannitol-Containing Dry Powder Inhalers for the Treatment of Cystic Fibrosis
by: Petra Party, et al.
Published: (2024)

An aerosol formulation of R-salbutamol sulfate for pulmonary inhalation
by: Xuemei Zhang, et al.
Published: (2014)

The future of inhalation therapy in chronic obstructive pulmonary disease
by: Mario Cazzola, et al.
Published: (2022)

Pharmaceutical strategies to extend pulmonary exposure of inhaled medicines
by: Yi Guo, et al.
Published: (2021)

Pulmonary Function Tests and Their Reversibility in Smokers
by: Ghanshyam B Borisagar, et al.
Published: (2014)

Inhaled Nitric Oxide Reverses Vascular and Respiratory Effects of ET-1 and PAF in Pigs
by: Mariangela Albertini, et al.
Published: (1994)

An Acute Pulmonary Coccidioidomycosis Coinfection in a Patient Presenting With Multifocal Pneumonia With COVID-19
by: Cameron Casey Chang MD, et al.
Published: (2020)

Digital Tracking of Physical Activity, Heart Rate, and Inhalation Behavior in Patients With Pulmonary Arterial Hypertension Treated With Inhaled Iloprost: Observational Study (VENTASTEP)
by: Barbara Stollfuss, et al.
Published: (2021)

Ibuprofen plasma concentration profile in deliberate ibuprofen overdose with circulatory depression treated with therapeutic plasma exchange: a case report
by: Stefanie Geith, et al.
Published: (2017)

Does Inhalation of Virgin Coconut Oil Accelerate Reversal of Airway Remodelling in an Allergic Model of Asthma?
by: N. A. Kamalaldin, et al.
Published: (2017)

Chronic obstructive pulmonary disease treated with inhaled medium- or high-dose corticosteroids: a prospective and randomized study focusing on clinical efficacy and the risk of pneumonia
by: Cheng SL, et al.
Published: (2014)

Inhalation Delivery for the Treatment and Prevention of COVID-19 Infection
by: Basanth Babu Eedara, et al.
Published: (2021)

Nanocrystals based pulmonary inhalation delivery system: advance and challenge
by: Pengfei Yue, et al.
Published: (2022)

Beyond the inhaled nitric oxide in persistent pulmonary hypertension of the newborn
by: Mei-Yin Lai, et al.
Published: (2018)

Pulmonary Targeting of Inhalable Moxifloxacin Microspheres for Effective Management of Tuberculosis
by: Bhavya Vishwa, et al.
Published: (2021)

Liquisolid ibuprofen tablets
by: Lannie Hadisoewignyo, et al.
Published: (2011)

Invasive pulmonary aspergillosis in critically ill patients with pneumonia due to COVID-19, influenza, and communityacquired pneumonia: A prospective observational study
by: Ahsan Syed, et al.
Published: (2022)

The role of afferent pulmonary innervation in ARDS associated with COVID-19 and potential use of resiniferatoxin to improve prognosis: A review
by: Alexis Nahama, et al.
Published: (2020)

Inhalable, Spray-Dried Terbinafine Microparticles for Management of Pulmonary Fungal Infections: Optimization of the Excipient Composition and Selection of an Inhalation Device
by: Khaled Almansour, et al.
Published: (2021)

Pulmonary delivery of liposomal dry powder inhaler formulation for effective treatment of idiopathic pulmonary fibrosis
by: S. Chennakesavulu, et al.
Published: (2018)

Inhaled antiseptics and inhaled antiviral non-prescription drugs in the prevention of ARVI, in particular COVID-19: an epidemiological study
by: Yu.I. Feshchenko, et al.
Published: (2021)

Pulmonary Edema in COVID-19 Patients: Mechanisms and Treatment Potential
by: Xinyu Cui, et al.
Published: (2021)

Cytomegalovirus pneumonia with pulmonary mucormycosis
by: Mysorekar Vijaya, et al.
Published: (2008)

Surgical tactics for the treatment of subpleural and intra-pulmonary hematomas as a result of pneumonia caused by COVID-19
by: M.S. Opanasenko, et al.
Published: (2023)

Errors in inhaler use related to devices and to inhalation technique among patients with chronic obstructive pulmonary disease in primary health care
by: Annika Lindh, et al.
Published: (2019)

Case Report: Can Inhaled Adenosine Attenuate COVID-19?
by: Bruce D. Spiess, et al.
Published: (2021)